Stroke is the second leading cause of death in the world. Unfortunately, only a few drugs have been proved in clinical trials. Drug development of the last decade has been focused substantially on a promising and heterogeneous group of neuroprotective drugs. Hundreds of compounds were suggested as new putative neuroprotectors, which effectiveness was confirmed in preclinical trials only. At the present time discrepancy between results of preclinical studies and clinical trials requires careful analysis. One of the least evaluated and probably the most noticeable reasons is general anesthesia - an obligatory component of an overwhelming majority of existing animal stroke models. The aim of the review is to describe known mechanisms of common general anesthetics influence on ionotropic and metabotropic plasma membrane receptors, and key signal pathways involved in neuronal hypoxic-ischemic injury and survival
Download PDF:
Keywords: general anesthetics, neuroprotection, signal pathways, stroke models
Citation:
Laletin V.S., Bykov Y.N. (2015) General anesthetics as a factor of effective neuroprotection in ischemic stroke models. Biomeditsinskaya Khimiya, 61(4), 440-448.
Laletin V.S. et al. General anesthetics as a factor of effective neuroprotection in ischemic stroke models // Biomeditsinskaya Khimiya. - 2015. - V. 61. -N 4. - P. 440-448.
Laletin V.S. et al., "General anesthetics as a factor of effective neuroprotection in ischemic stroke models." Biomeditsinskaya Khimiya 61.4 (2015): 440-448.
Laletin, V. S., Bykov, Y. N. (2015). General anesthetics as a factor of effective neuroprotection in ischemic stroke models. Biomeditsinskaya Khimiya, 61(4), 440-448.
World Health Organization. The global burden of disease: 2004 update. (2008) WHO Press. Scholar google search
Mackay J., Mensah G. (2004) The Atlas of Heart Disease and Stroke. World Health Organization. Scholar google search
World Health Organization. The 10 leading causes of death by broad income group. Fact sheet 310. (2008) World Health Organization. Scholar google search
World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. (2009) WHO Press. Scholar google search
IST-3 collaborative group, Sandercock P., Wardlaw J.M., Lindley R.I., Dennis M., Cohen G., Murray G., Innes K., Venables G., Czlonkowska A., Kobayashi A., Ricci S., Murray V., Berge E., Slot K.B., Hankey G.J., Correia M., Peeters A., Matz K., Lyrer P., Gubitz G., Phillips S.J., Arauz A. (2012) Lancet, 379(9834), 2352-2363. Scholar google search
Macleod M.R., Fisher M., O'Collins V., Sena E.S., Dirnagl U., Bath P.M., Buchan A., van der Worp H.B., Traystman R.J., Minematsu K., Donnan G.A., Howells D.W. (2009) J. Cereb. Blood Flow Metab., 29, 221-223. Scholar google search